-
One of the biggest ethical challenges with drug safety is the need for patients and providers to understand that even after a drug is approved, there is still more to learn about its benefits and potential harms, according to Ruth R. Faden, PhD, MPH, Philip Franklin Wagley Professor of Biomedical Ethics and Director of the Johns Hopkins Berman Institute of Bioethics in Baltimore, MD.
-
Two-thirds of medical students and residents believe there is a need for more ethics training during their curricula and training programs, according to a survey of 129 medical students and 207 residents done in 2009 and 2010 at University of Maryland School of Medicine in Baltimore.
-
The Presidential Commission for the Study of Bioethical Issues offered 14 recommendations for improving oversight of human subjects' research:
-
Researchers and review boards should pay close attention to informed consent comprehension among all research participants, but this attentiveness is especially needed for people from a high-risk population.
-
-
Donor Alliance, a Denver-based federally designated non-profit organ procurement organization, and American Association of Tissue Banks (AATB), a McLean, VA-based accredited tissue bank, have announced results from an initiative designed to study the public's perception of organ, eye, and tissue donation.
-
The U.S. Supreme Court has recently thrown out a lower court ruling that allows human genes to be patented. This topic is of great importance to cancer researchers, patients, and drugmakers.
-
On Nov. 24, 2009, President Obama established The Presidential Commission for the Study of Bioethical Issues to advise him on bioethical issues generated by novel and emerging research in biomedicine and related areas of science and technology.
-
Add another voice to the national conversation on improving protection of research participants: The Presidential Commission for the Study of Bioethical Issues, which recently released its recommendations for reforming federal oversight of human subjects' research.
-
In a commentary on the biosecurity controversy surrounding publication of bird flu research details, a bioethicist and a vaccine expert at Johns Hopkins reaffirm that "all scientists have an affirmative ethical obligation to avoid contributing to the advancement of biowarfare and bioterrorism," but that there are not sufficient structures in place to evaluate potential societal risks.
